复合Kushen注射通过调节Piezo1-介导的NF-κB/NLRP3通路来改善M1巨细胞极化和辐射诱导的大肠炎

Xin Sun1, Zheng Li2, Shangfei Luo1

  • 1Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road Changqing District, Ji'nan, Shandong 250355, China.

概括

复合Kushen注射 (CKI) 通过抑制巨细胞中的Piezo1激活来预防辐射诱导性结肠炎 (RIC). 这种Piezo1-NF-κB/NLRP3通路的调节减少了炎症并改善了RIC的结果.